Targeting DNA Repair Defects Through PARPi in mPC: Why Are Somatic/Germline Alterations Important? How Can We Selectively Stop BRCA-Mutated Disease? Do BRCA 2 Carriers Have Worse Prognosis? What Are the Current NCCN Testing Guidelines?